20 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
6
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells.
University of Pisa
2
Development of a novel class of glucose transporter inhibitors.
The Ohio State University
8
Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus.
Mitsubishi Tanabe Pharma
2
Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.
University of Kuopio
23
Recent Progress in the Development of Glucose Transporter (GLUT) Inhibitors.
Southern Medical University
1
Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876.
Virginia Commonwealth University School of Medicine
1
GLUT4 expression and glucose transport in human induced pluripotent stem cell-derived cardiomyocytes.
University of Glasgow
64
Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876.
Bayer AG
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.
Johann Wolfgang Goethe University
8
Interaction of O-(undec-10-en)-yl-D-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT).
Université
3
Target Separation and Potential Anticancer Activity of Withanolide-Based Glucose Transporter Protein 1 Inhibitors from
China Pharmaceutical University
4
Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential.
Bharati Vidyapeeth's College of Pharmacy
3
Monosaccharide Analogues of Anticancer Peptide R-Lycosin-I: Role of Monosaccharide Conjugation in Complexation and the Potential of Lung Cancer Targeting and Therapy.
TBA
19
Development of GLUT4-selective antagonists for multiple myeloma therapy.
Emory University
17
(Aminoalkyl)carbamates of forskolin: intermediates for the synthesis of functionalized derivatives of forskolin with different specificities for adenylyl cyclase and the glucose transporter.
Food and Drug Administration
